Teratogenic potential of almokalant, dofetilide, and d-sotalol: Drugs with potassium channel blocking activity

Teratology

Volumn 53, Issue 3, 1996, Pages 168-175

  Webster, W S ^a   Brown Woodman, P D C ^a   Snow, M D ^a   Danielsson, B R G ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOKALANT; ANTIARRHYTHMIC AGENT; DOFETILIDE; POTASSIUM CHANNEL BLOCKING AGENT; SOTALOL; TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CLEFT LIP; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYO DEATH; EMBRYOTOXICITY; FEMALE; FETUS HEART RATE; FETUS MALFORMATION; HEART MUSCLE ISCHEMIA; HYPOPLASIA; HYPOXIA; ISCHEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGANOGENESIS; PRIORITY JOURNAL; RAT; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CLEFT PALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HEART RATE, FETAL; LIMB DEFORMITIES, CONGENITAL; MALE; ORGAN CULTURE TECHNIQUES; PHENETHYLAMINES; POTASSIUM CHANNEL BLOCKERS; PREGNANCY; PREGNANCY OUTCOME; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; SOTALOL; SULFONAMIDES;

EID: 0029905292     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199603)53:3<168::AID-TERA4>3.0.CO;2-0     Document Type: Article

References (24)

1. Abrahamsson C., M. Palmer, B. Ljung, G. Duker, C. Baarnhielm, L. Carlsson, and B. Danielsson (1994) Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of class III antiarrhythmic agent almokalant. Cardiovasc. Res., 28:337-344.
2. Ban, Y., R. Konishi, K. Kawana, T. Nakatsuka, and T. Fujii (1992) Embryotoxic effects of class III antiarrhythmic agent, L-691,121, in rats. Teratology, 45:462.
3. Beyer T., J. Branchmann, and W. Kubler (1993) Comparative effects of d-sotalol and 1-sotalol on the atrioventricular node of the rabbit heart. J. Cardiovasc. Pharmacol., 22:240-246.
4. Carmeliet, E. (1985) Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibres. J. Pharmacol. Exp. Ther., 232:817-825.
5. + current in cardiac myocytes by dofetilide. J. Pharmacol. Exp. Ther., 262:809-817.
6. + current by almokalant in rabbit ventricular myocytes. Circ. Res., 73:857-868.
7. Danielsson, B.R. (1993) Malformations and fetal hypoxia induced by exaggerated pharmacological effects. In: Developmental toxicology - Preclinical and clinical data in retrospect. A. Sundvall, B.R. Danielsson, O. Hagberg, E. Lindgren, P. Sjoberg, and A. Victor, eds. Tryckgruppen, Stockholm, pp. 44-57.
8. Danielsson, B.R. (1994) Malformations and hypoxia induced by pharmacological action. Teratology, 49:238 (abst.).
9. Fantel, A.G., C.V. Barber, and B. Mackler (1992) Ischemia/reperfusion: A new hypothesis for the developmental toxicity of cocaine. Teratology, 46:285-292.
10. Franklin, J.B., and R.L. Brent (1964) The effect of uterine vascular clamping on the development of rat embryos three to fourteen days old. J. Morphol., 115:273-290.
11. Kawana, R., R. Konishi, Y. Ban, T. Nakatsuka, and T. Fujii (1992) In vivo embryotoxic effects of a class III antiarrhythmic agent L-691,121, in rats. Teratology, 46:19B.
12. Konishi, R., Y. Ban, K. Kawana, T. Nakatsuka, and T. Fujii (1992) In vitro embryotoxic effects of a class III antiarrhythmic agent L-691,121, in rats using whole embryo culture. Teratology, 46:11B.
13. Leist, K.H., and J. Grauwiler (1973) Influence of the developmental stage on embryotoxicity following uterine vessel clamping in the rat. Teratology, 8:227-228.
14. Lynch, J.J., A.A. Wallace, E.P. Van der Gaag, C.M. Baskin, J.R. Bear, T. Gehret, R.F. Kothstein, S.D. Stupienski, M.C. Appelby, N.K. Sanguinetti, G.J. Jurkiewicz, R.B. Zingaro, D.A. Stein, J.M. Claremon, M.B. Elliott, J.J. Young, and J.J. Baldwin (1993) Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1-[benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4-piperidin]-4-one HCl (L-691,121), a novel class III agent. J. Pharmacol. Exp. Ther., 265:720-730.
15. New, D.A.T. (1978) Whole embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev., 53:81-122.
16. O'Hare, M.F., W. Leahey, G.A. Murnaghan, and D.G. McDevitt (1983) Pharmacokinetics of sotalol during pregnancy. Eur. J. Clin. Pharmacol., 24:521-524.
17. Rasmussen, H.S., M.J. Allen, K.J. Blackburn, G.S. Butrous, and H.W. Dalrymple (1992) Dofetilide, a novel class III antiarrhythmic agent. J. Cardiovasc. Pharmacol., 20:S96-S105.
18. Robkin, M.A., T.H. Shepard, and T. Tanimura (1972) A new in vitro technique for rat embryos. Teratology, 5:367-376.
19. Robkin, M.A., T.H. Shepard, and D. Baum (1974) Autonomic drug effects on the heart rate of early rat embryos. Teratology, 9:35-44.
20. + current. J. Gen. Physiol., 96:195-215.
21. Smith D.A., H.S. Rasmussen, D.A. Stopher, and D.K. Walker (1992) Pharmacokinetics and metabolism of dofetilide in mouse, rat dog and man. Xenobiotica, 22:709-719.
22. Spence, G.S., C. Vetter, and C-M. Hoe (1994) Effects of the class III antiarrhythmic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos in vitro. Teratology, 49:282-292.
23. Webster, W.S., A.H. Lipson, and P.D.C. Brown-Woodman (1987) Uterine trauma and limb defects. Teratology, 35:253-260.
24. Webster, W.S., and P.D.C. Brown-Woodman (1990) Cocaine as a cause of congenital malformations of vascular origin: Experimental evidence in the rat. Teratology, 41:689-697.